PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label KEYTRUDA. Show all posts

Showing posts with label KEYTRUDA. Show all posts

FDA Approves Expanded Indication of KEYTRUDA in Melanoma

Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for KEYTRUDA ® (pembrolizumab),...

Amgen to Present IMLYGIC Data

Amgen announced that the Company will present eight IMLYGIC (talimogene laherparepvec) abstracts, including data from the Phase 3 trial a...

Merck Receives Breakthrough Therapy Designation from USFDA

Merck announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA ® ...

New Findings Show Anti-Tumor Activity of KEYTRUDA

Merck announced the first-time presentation of findings investigating the use of KEYTRUDA ® (pembrolizumab), the company’s anti-PD-1 ther...

Merck and MD Anderson Cancer Center in Collaboration

Merck and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical r...

View web version

Powered by Blogger.